JDALLILAB

Jesmond Dalli is Professor of Molecular Pharmacology at the Barts and The London School of Medicine and Dentistry and Queen Mary University of London. He is the Director of the QMUL Lipid Mediator Unit at the William Harvey Research Institute. He received a BSc (Hons) in chemistry and biology and an MSc in biology from the University of Malta. He then read for and completed a PhD at the William Harvey Research Institute, Queen Mary University of London with Prof Mauro Perretti. Prof Dalli subsequently moved to Prof Charles N. Serhan’s laboratory at Harvard Medical school and the Brigham and Women’s Hospital where he held a faculty post and was the co-director of two NIH funded lipid mediator profiling cores.

Dr Soumik Basu is a Clinical Research Fellow working as a Registrar in ENT Department at Barts Health NHS Trust. He completed his medical school (MBBS) at N.R.S Medical College Kolkata, India (2008), later obtained Master of Surgery (DLO, DNB and MS-2016) in Otolaryngology from IPGMER (India). He had his MRCS ENT from Royal College of Surgeons of England (2019) and currently attached to the Lipid Mediator Unit as a Guest Researcher (2021). He is working on a project named ‘Resolving ENT’ that investigates dysregulation of Resolution pathway in relation to the pathogenesis of various diseases in the head and neck region.  His particular area of interest is Head and neck Squamous Cell carcinoma (HNSCC) -whether a dysregulated SPM pathway contributes in the pathogenesis, progression and metastasis of HNSCC.

Vishaka Gorur is a Clinical Research Fellow pursuing her PhD at the Lipid Mediator Unit of the William Harvey Research Institute. She obtained her bachelor’s degree in medicine (MBBS) from Rajiv Gandhi university of Health Sciences, Karnataka, India in 2010. She has then completed her Core Medical Training in the National Health Service in the UKacquiring a Membership of the Royal College of Physicians(MRCP), UK in 2016.  Additionally, she has a Master of Science degree in Biomedical Sciences(Haematology) from the University of Westminster(2015) and a Post Graduate Certificate in public health obtained from London School of hygiene and Tropical Medicine in 2016. She started her Clinical Haematology registrar training in the Northeast London Deanery in 2018 and has developed a special interest in Haemoglobinopathies. Currently, she is working on a project exploring the role of Specialised Pro-resolving mediators in chronic inflammation in Sickle cell disease as a part of her PhD. 

Emmanuel Albuquerque-Souza is a UKRI Marie Sklodowska-Curie Postdoctoral Fellow at the Lipid Mediator Unit of the William Harvey Research Institute. He graduated as Doctor of Dental Surgery (2010) and obtained his Master of Science in Dental Medicine (2014) from the Paraiba State University, Brazil and earned his PhD in Periodontology (2018) from the University of São Paulo, Brazil. He completed a Research Internship at the Forsyth Institute, Harvard School of Dental Medicine Affiliate, USA (2017-2018) and worked as Postdoctoral Researcher at the University of Pennsylvania, USA (2021-2022). He has an h-index of 11 according to the Web of Science and his publications can be found on https://orcid.org/0000-0002-7307-0283. Throughout his career he has been studying the patterns of symbiosis (or dysbiosis) established between the microbiota and the host response with particular emphasis on the innate immunity and how these interactions can impact the susceptibility to chronic inflammatory diseases, especially colitis and periodontitis.

Matthew Dooley is a Staff Scientist in the Lipid Mediator Unit, primarily working within the mass spectrometry facility. He obtained a BSc (Hons) in Chemistry with Medicinal Chemistry from Keele University followed by a MRes in Drug Discovery from Imperial College London, involving the design and synthesis of novel antimicrobial resistance-targeting compounds under Professor Ed Tate.  

Amitis Saliani earned her BSc degree in Cell and Molecular Biology – Genetics at Tehran Azad University of Medical Sciences, Iran. She then participated in a Bioinformatics course at Tarbiat Modares University of Tehran, Iran in 2020. She moved to London to study a master’s programme in Genomic Medicine at Queen Mary University of London in 2021. For her master’s thesis, titled ‘Investigating the toxicity of Lyso-gb1 in Gaucher and Parkinson’s disease with the application of UPLC-TQS’, she worked at Institute of Child Health in UCL under the supervision of Dr. Wendy Heywood. She graduated from Queen Mary University of London in 2022 and started working as a research technician at the Lipid Mediator Unite based in William Harvey Research Institute with Professor Jesmond Dalli in January 2023.

Harriet Lee obtained her BSc in Neurobiology, Physiology and Behavior from the University of California, Davis, before moving to London in 2024 to complete an MSc in Bioinformatics at Queen Mary University of London. As a Staff Scientist, she splits her time between the mass spectrometry facility and developing data analysis applications used by the LMU.